# Pharmacokinetics in Pregnancy — Study Design, Data Analysis, and Impact on Dosing and Labeling - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/pharmacokinetics-in-pregnancy-study-design-data-analysis-and-impact-on-dosing-and-labeling/08e99d11-48f5-4d96-a72c-c66cde9d04ca

> FDA guidance document: Pharmacokinetics in Pregnancy — Study Design, Data Analysis, and Impact on Dosing and Labeling. Issue date: November 01, 2004. Get complete insights and analysis.

---

## Details

- Title: Pharmacokinetics in Pregnancy — Study Design, Data Analysis, and Impact on Dosing and Labeling
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2004-11-01
- Last Changed: 2020-04-27
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2004-D-0459">FDA-2004-D-0459</a>

## Related Documents

- [Bioavailability and Bioequivalence Studies Submitted in NDAs or INDs — General Considerations](https://www.globalkeysolutions.net/guidances/guidance-document/bioavailability-and-bioequivalence-studies-submitted-in-ndas-or-inds-general-considerations/0cbdcef4-1b6b-45e5-8563-de1bb0a4e001)
- [Physicochemical and Structural (Q3) Characterization of Topical Drug Products Submitted in ANDAs](https://www.globalkeysolutions.net/guidances/guidance-document/physicochemical-and-structural-q3-characterization-of-topical-drug-products-submitted-in-andas/791aaeaa-9e86-4bc4-8b71-477a833920f1)
- [Public Availability of Labeling Changes in "Changes Being Effected" Supplements](https://www.globalkeysolutions.net/guidances/guidance-document/public-availability-of-labeling-changes-in-changes-being-effected-supplements/0cd869a7-e345-4545-b817-9cde8e7c7438)